The inaugural Biomarkers And Diagnostics for Complex And Rare Diseases Summit will unite leading pharma, biotech, Dx and healthcare organizations to advance the application of precision medicine for therapeutic indications outside of oncology.
Tackling critical challenges in the discovery, translation, development and commercialization of biomarker-driven and Dx-enabled therapeutics, this meeting will draw on the transferable learnings from a multitude of disease areas to improve treatment decision making and push the boundaries of the standard of care for patients.
19th - 20th June, 2019
+1 415 735 3289
Drug Developer Conference Earlybird (Book by 15/02/19): USD 1599.0,
Drug Developer Conference (Standard rate): USD 2499.0,
Service Provider Conference Earlybird (Book by 15/02/19): USD 2299.0,
Service Provider Conference (Standard rate): USD 3199.0
Speakers: Franziska Moeckel (Inova Health System), George Bashirians (Pfizer), Kenneth Rhodes (Yumanity Therapeutics), Naomi Aronson (Blue Cross Blue Shield Association), Gabriel Cohn (AvroBio), Michael Hutton (Eli Lilly And Co.)